These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 25015705)
21. Skin cancer surveillance in renal transplant recipients: re-evaluation of U.K. practice and comparison with Australian experience. Garg S; Carroll RP; Walker RG; Ramsay HM; Harden PN Br J Dermatol; 2009 Jan; 160(1):177-9. PubMed ID: 18798841 [TBL] [Abstract][Full Text] [Related]
22. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients. Durando B; Reichel J Dermatol Ther; 2005; 18(1):1-11. PubMed ID: 15842607 [TBL] [Abstract][Full Text] [Related]
23. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution. Ng JC; Cumming S; Leung V; Chong AH Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627 [TBL] [Abstract][Full Text] [Related]
24. Skin cancer after transplantation. Kovach BT; Stasko T Transplant Rev (Orlando); 2009 Jul; 23(3):178-89. PubMed ID: 19345080 [TBL] [Abstract][Full Text] [Related]
25. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Veness MJ; Harris D Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484 [TBL] [Abstract][Full Text] [Related]
26. Management of Cutaneous Cancers in Patients Undergoing Organ Transplantation-Part I: Current Status: Reactive Approach. Sharma D; Handler MZ; Shah R; Weiss A; Lambert MW; Gagna CE; Lambert WC Skinmed; 2017; 15(5):329-331. PubMed ID: 29139358 [No Abstract] [Full Text] [Related]
28. French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin. Bejar C; Basset-Seguin N; Faure F; Fieschi C; Frances C; Guenne C; Lebbe C; Peraldi MN; Roux J; Lamas G; Maubec E; Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Apr; 131(2):121-9. PubMed ID: 24656876 [TBL] [Abstract][Full Text] [Related]
29. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features. Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691 [TBL] [Abstract][Full Text] [Related]
30. Management of skin cancer after organ transplantation. Lumbang W; Stasko T G Ital Dermatol Venereol; 2011 Oct; 146(5):341-52. PubMed ID: 21956271 [TBL] [Abstract][Full Text] [Related]
31. Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients. McKenna KE Photodermatol Photoimmunol Photomed; 2004 Dec; 20(6):289-96. PubMed ID: 15533236 [TBL] [Abstract][Full Text] [Related]
32. Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature. Džambová M; Sečníková Z; Jiráková A; Jůzlová K; Viklický O; Hošková L; Göpfertovà D; Hercogová J Dermatol Ther; 2016; 29(1):64-8. PubMed ID: 26460720 [TBL] [Abstract][Full Text] [Related]
34. Vismodegib for locally advanced basal cell carcinoma in a heart transplant patient. Cusack CA; Nijhawan R; Miller B; Henien M; Malat G; Doyle A; Abdelmalek M JAMA Dermatol; 2015 Jan; 151(1):70-2. PubMed ID: 25337679 [TBL] [Abstract][Full Text] [Related]
35. Keratinocyte cancer and its precursors in organ transplant patients. Jenni D; Hofbauer GF Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206 [TBL] [Abstract][Full Text] [Related]
36. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]. Lapointe AK; Hofbauer G; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Pascual M; Pelloni F; Serra A; Laffitte E Rev Med Suisse; 2010 Apr; 6(246):854-9. PubMed ID: 20455382 [TBL] [Abstract][Full Text] [Related]